What an incredible week at CPHI India 2025 in Delhi! 🇮🇳
Beyond the productive meetings and technical discussions, we truly enjoyed the energy, hospitality, and enthusiasm from everyone we met. It was a pleasure reconnecting with colleagues, partners, and friends—and meeting so many new faces across the peptide and oligonucleotide community.
From conversations on CMC development to large-scale manufacturing strategies, generics, DMFs, and FDA-compliant GMP readiness, the engagement was outstanding. Thank you to everyone who took the time to stop by, share insights, and explore how Sinopep can support your programs—from early development through late-phase and commercial manufacturing.
We also had great discussions on partnering with Sinopep for generics in collaboration with qualified compounding pharmacies.
If we didn’t get a chance to connect onsite, we’d still love to hear from you.
You can reach us at:
Looking forward to continuing the great conversations from Delhi!
